The utility of pre-clinical trials in glioblastoma patientderived xenografts (PDXs) models for informing clinical trial development of therapeutic strategies

被引：0
|
作者：
Burgenske, Danielle M.
Mladek, Ann C.
Bakken, Katrina K.
Hu, Zeng
Carlson, Brett L.
Decker, Paul A.
Eckel-Passow, Jeanette E.
Sarkaria, Jann N.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-A002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Abstract A
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Emerging Pro-neurogenic Therapeutic Strategies for Neurodegenerative Diseases: A Review of Pre-clinical and Clinical Research
    Vassal, Mariana
    Martins, Filipa
    Monteiro, Bruno
    Tambaro, Simone
    Martinez-Murillo, Ricardo
    Rebelo, Sandra
    MOLECULAR NEUROBIOLOGY, 2025, 62 (01) : 46 - 76
  • [32] Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts
    Koi, Lydia
    Bitto, Verena
    Weise, Corina
    Moebius, Lisa
    Linge, Annett
    Loeck, Steffen
    Yaromina, Ala
    Besso, Maria Jose
    Valentini, Chiara
    Pfeifer, Manuel
    Overgaard, Jens
    Zips, Daniel
    Kurth, Ina
    Krause, Mechthild
    Baumann, Michael
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [33] Recent advances and novel strategies in pre-clinical formulation development: An overview
    Shah, Amit K.
    Agnihotri, Sunil A.
    JOURNAL OF CONTROLLED RELEASE, 2011, 156 (03) : 281 - 296
  • [34] Development of Pre-Clinical Models for Evaluating the Therapeutic Potential of Candidate siRNA Targeting STAT6
    Healey, Gareth D.
    Lockridge, Jennifer A.
    Zinnen, Shawn
    Hopkin, Julian M.
    Richards, Ivan
    Walker, William
    PLOS ONE, 2014, 9 (02):
  • [35] Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials
    Atkins, Johnique T.
    George, Goldy C.
    Hess, Kenneth
    Marcelo-Lewis, Kathrina L.
    Yuan, Ying
    Borthakur, Gautam
    Khozin, Sean
    LoRusso, Patricia
    Hong, David S.
    BRITISH JOURNAL OF CANCER, 2020, 123 (10) : 1496 - 1501
  • [36] Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials
    Johnique T. Atkins
    Goldy C. George
    Kenneth Hess
    Kathrina L. Marcelo-Lewis
    Ying Yuan
    Gautam Borthakur
    Sean Khozin
    Patricia LoRusso
    David S. Hong
    British Journal of Cancer, 2020, 123 : 1496 - 1501
  • [37] Animal models of disease: Pre-clinical animal models of cancer and their applications and utility in drug discovery
    Ruggeri, Bruce A.
    Camp, Faye
    Miknyoczki, Sheila
    BIOCHEMICAL PHARMACOLOGY, 2014, 87 (01) : 150 - 161
  • [38] Mouse models of myeloproliferative neoplasms for pre-clinical testing of novel therapeutic agents
    Stetka, Jan
    Skoda, Radek C.
    BIOMEDICAL PAPERS-OLOMOUC, 2021, 165 (01): : 26 - 33
  • [39] Pre-Clinical Mouse Models of SCLC to Identify and Validate New Therapeutic Targets
    Lim, Jing
    Jahchan, Nadine
    Yang, Dian
    George, Julie
    Peifer, Martin
    Thomas, Roman K.
    Sage, Julien
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S99 - S99
  • [40] Pre-clinical models of small cell lung cancer and the validation of therapeutic targets
    Sui, Jane S. Y.
    Martin, Petra
    Gray, Steven G.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (03) : 187 - 204
12345